Close
Solutions
Online Inquiry
Global Services

Canine CAR-T Cell Characterization Service

Online Inquiry

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Creative Biolabs is committed to providing canine CAR-T characterization validation services to best suit the client's program requirements.

Importance of CARTs Characterization Validation

Preclinical studies reveal the promise and challenges of CAR-T development and therapy. CARTs preclinical evaluation, including a range of responses, such as CARTs activation and exhaustion, tumor killing, and cytokine production, is crucial to the development and optimization of CAR-T cell therapies. These comprehensive evaluation tests usually need to be carried out through multiple dimensions and need to take into account multiple influencing factors. For example, the selection of experimental types, the selection of tumor cells in vitro, the establishment of experimental models in vivo, and so on.

Fig.1 Canine CAR-T therapy. (Cockey & Cynthia A, 2023)Fig.1 Overall scheme for CAR therapy in veterinary medicine.1

Our Canine CAR-T Characterization Validation Service

Leveraged by advanced technology platforms and years of experience, Creative Biolabs has launched a full range of evaluation analysis services for global customers to facilitate canine CAR-T research. Our services are featured with the following assays. In addition to these assays, we also provide customized development experiments according to customers' project needs.

Published Data

  • Paper Title: Optimization of canine CD20 chimeric antigen receptor T cell manufacturing and in vitro cytotoxic activity against B cell lymphoma.
  • Summary: The researchers designed and established 2nd and 3rd cCD20-ζ CAR-T cells using the retrovirus transfection method. The 2nd and 3rd cCD20-ζ CAR-T cells showed cytotoxicity and target specificity in in-vitro functional evaluation.
  • Technology: Retroviral transfection;
  • Cell Type: Canine PBMC;
  • In Vitro Tumor Model: Canine B cell lymphoma cell line CLBL-1;
  • Results:

Frequently Asked Questions

Q1. For canine CAR-T development, how does Creative Biolabs select target tumor cells for different targets?

A: In the development, we will first communicate with the customer whether there are relevant reference data or literature. If the target is really rare and appropriate tumor cells cannot be found, we will construct overexpressed cell lines to meet the experimental requirements.

Q2. How does Creative Biolabs secure the source of cells for canine CAR-T development?

A: We strictly abide by the related requirements. PBMC samples collected from blood donors on the day of product collection are tested following related requirements for blood transfusion.

If there is any query, please contact us for more details about the canine CAR-T cell characterization service.

Reference

  1. Cockey, James R., and Cynthia A. Leifer. "Racing CARs to veterinary immuno-oncology." Frontiers in Veterinary Science 10 (2023): 1130182.
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.